Majumder B, Venkatachari NJ, Ayyavoo V. (2008) Human Immunodeficiency Virus type 1 Viral Protein R (HIV-1Vpr) impairs NK cell activation through dysregulation of infected target cells. J Virol. 82:7189-200.
Venkatachari NJ, Buchanan WG, Ayyavoo V. (2008) Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo. Virology 376:140-53.
Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V. (2009) HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). Curr HIV Res. 7:169-77.
Venkatachari NJ, Alber S, Watkins SC, Ayyavoo V. (2009) HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism. PLoS One. 4: 7470.
Venkatachari NJ, Walker LA, Tastan O, Le T, Dempsey TM, Li Y, Yanamala N, Srinivasan A, Klein-Seetharaman J, Montelaro RC, Ayyavoo V. (2010) Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virology J. 7:119.
Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten G Ayyavoo V. (2012) Neuronal apoptosis by HIV-1 Vpr: Contribution of pro-inflammatory molecular networks from infected target cells. J Neuroinflammation 9:138-152.
Duskova K, Nagilla P, Le H, Iyer P, Thalamuthu A, Martinson J, Bar-Joseph Z, Buchanan W, Rinaldo C, Ayyavoo V. (2013) MicroRNA regulation and its effects on cellular transcriptome in Human Immunodeficiency Virus-1 (type-1) infected individuals with distinct viral load and CD4 cells. BMC Genomics 13:250.
Zych C, Domling A, Ayyavoo V. (2013) Development of a robust cell- based high-throughput screening assay to identify targets of HIV-1 Vpr dimerization. J. Drug Design Develop. Therapy 7:403-412.
Hadi K, Walker LA, Tarwater P, Srinivasan A, Ayyavoo V. (2014) Human Immunodeficiency Virus- type 1 (HIV-1) Vpr polymorphisms associated with progressors and non-progressor individuals alter Vpr associated functions. J. Gen. Virol. 95:700-711.
Guha D, Klamar CR, Reinhart T, Ayyavoo V. (2015) Transcriptional regulation of CXCL5 in HIV-1-infected macrophages and its functional consequences on CNS Pathology. J. Interferon Cytokine Res. 35:373-384.
Venkatachari NJ, Zerbato JM, Jain S, Mancini AE, Chattopadhyay A, Suis-Cremer N, Bar-Joseph Z, Ayyavoo V. (2015) Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch. Retrovirol. 12:85.
Jain S, Arrais J, Venkatachari NJ, Ayyavoo V, Bar-Joseph Z. (2016) Reconstructing the temporal progression of HIV-1 immune response pathways. Bioinformatics 32:i253-i261.
Guha D, Mancini A, Sparks J, Ayyavoo V. (2016) HIV-1 infection dysregulates cell cycle regulatory protein p21 in CD4+ T cells through miR-20a and miR-106b regulation. J Cell Biochem 11:1902-1912.
Venkatachari NJ, Jain S, Walker L, Bivalkar-Mehla S, Chattopadhyay A Bar-Joseph Z, Rinaldo C Ragin A, Seaberg E, Levine A, Becker J, Martin E, Sacktor N, Ayyavoo V. (2017) Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men. AIDS 31:623-633.
For a full list publications, click this link: https://www.ncbi.nlm.nih.gov/pubmed/?term=ayyavoo+v